Bank of New York Mellon Corp - AYTU BIOPHARMA INC ownership

AYTU BIOPHARMA INC's ticker is AYTU and the CUSIP is 054754874. A total of 72 filers reported holding AYTU BIOPHARMA INC in Q1 2021. The put-call ratio across all filers is 0.89 and the average weighting 0.0%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of AYTU BIOPHARMA INC
ValueSharesWeighting
Q4 2022$1,968
-1.6%
10,4140.0%0.00%
Q3 2022$2,000
-71.4%
10,4140.0%0.00%
Q2 2022$7,000
-36.4%
10,4140.0%0.00%
Q1 2022$11,000
-21.4%
10,4140.0%0.00%
Q4 2021$14,000
-53.3%
10,4140.0%0.00%
Q3 2021$30,000
-62.5%
10,414
-34.6%
0.00%
Q2 2021$80,000
-77.5%
15,919
-66.0%
0.00%
Q1 2021$356,000
+300.0%
46,833
+215.2%
0.00%
Q4 2020$89,00014,8570.00%
Other shareholders
AYTU BIOPHARMA INC shareholders Q1 2021
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 1,342,378$6,725,0000.12%
Tibra Equities Europe Ltd 60,100$301,0000.09%
Virtu Financial LLC 101,805$510,0000.05%
OCCUDO QUANTITATIVE STRATEGIES LP 60,928$305,0000.05%
Pinz Capital Management, LP 21,400$107,0000.03%
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC 10,880$55,0000.02%
WINTON GROUP Ltd 57,229$287,0000.02%
Ergoteles LLC 75,472$378,0000.01%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 54,819$275,0000.01%
ExodusPoint Capital Management, LP 53,859$270,0000.00%
View complete list of AYTU BIOPHARMA INC shareholders